NISSAY ASSET MANAGEMENT CORP /JAPAN/ /ADV - BAXTER INTL INC ownership

BAXTER INTL INC's ticker is BAX and the CUSIP is 071813109. A total of 1,090 filers reported holding BAXTER INTL INC in Q2 2021. The put-call ratio across all filers is 1.03 and the average weighting 0.2%.

About BAXTER INTL INC

Baxter International Inc. is a global healthcare company that specializes in developing and manufacturing medical products and therapies. The company has a long history of innovation and has been at the forefront of developing life-saving treatments for patients around the world.

Baxter's product portfolio includes a wide range of medical devices, pharmaceuticals, and biotechnology products. The company's products are used in hospitals, clinics, and other healthcare settings to treat a variety of conditions, including hemophilia, immune disorders, kidney disease, and other chronic and acute medical conditions.

Baxter's commitment to innovation has helped the company maintain a strong position in the healthcare industry. The company invests heavily in research and development, and has a strong pipeline of new products in development.

Baxter's leadership team is also a key strength of the company. The CEO, José Almeida, has a strong track record of success in the healthcare industry, and has been instrumental in driving the company's growth and success.

Overall, Baxter International Inc. is a strong and innovative company that is well-positioned to continue delivering value to patients, healthcare providers, and investors alike. With a strong product portfolio, a commitment to innovation, and a talented leadership team, Baxter is a company that investors should keep an eye on in the years to come.

It's important to note that this information is for educational purposes only and has not been fact-checked. As with any investment, it's important to do your own research and consult with a financial advisor before making any investment decisions.

Quarter-by-quarter ownership
NISSAY ASSET MANAGEMENT CORP /JAPAN/ /ADV ownership history of BAXTER INTL INC
ValueSharesWeighting
Q3 2023$2,221,716
-14.3%
58,869
+3.4%
0.02%
-9.1%
Q2 2023$2,592,774
+10.8%
56,909
-1.4%
0.02%
+4.8%
Q1 2023$2,340,717
-23.2%
57,710
-3.5%
0.02%
-27.6%
Q4 2022$3,049,484
-5.7%
59,829
-0.3%
0.03%
-14.7%
Q3 2022$3,233,000
-12.9%
60,027
+3.9%
0.03%
-8.1%
Q2 2022$3,710,000
-16.7%
57,766
+0.5%
0.04%
-5.1%
Q1 2022$4,456,000
-7.5%
57,470
+2.4%
0.04%
+5.4%
Q4 2021$4,816,000
+9.4%
56,109
+2.5%
0.04%0.0%
Q3 2021$4,402,000
+3.5%
54,730
+3.6%
0.04%0.0%
Q2 2021$4,252,000
+1.0%
52,824
+5.8%
0.04%
-11.9%
Q1 2021$4,211,000
+3.6%
49,927
-1.4%
0.04%
-31.1%
Q4 2020$4,064,000
-32.0%
50,647
-31.8%
0.06%
-39.6%
Q3 2020$5,976,000
+11.4%
74,316
+19.3%
0.10%
-2.9%
Q2 2020$5,363,000
-16.0%
62,289
-20.8%
0.10%
-36.2%
Q1 2020$6,383,000
+43.0%
78,616
+47.3%
0.16%
+64.6%
Q4 2019$4,464,000
-10.9%
53,386
-6.8%
0.10%
-19.5%
Q3 2019$5,012,000
-25.4%
57,296
-30.2%
0.12%
-27.6%
Q2 2019$6,723,000
-10.1%
82,090
-10.7%
0.17%
-14.1%
Q1 2019$7,476,000
+10.5%
91,939
-10.6%
0.20%
-3.9%
Q4 2018$6,767,000
-15.0%
102,814
-0.5%
0.21%
-3.7%
Q3 2018$7,965,000
-13.7%
103,325
-17.3%
0.21%
-20.7%
Q2 2018$9,231,000
+29.1%
125,013
+13.8%
0.27%
+21.1%
Q1 2018$7,148,000
+55.9%
109,899
+55.0%
0.22%
+59.3%
Q4 2017$4,586,00070,9180.14%
Other shareholders
BAXTER INTL INC shareholders Q2 2021
NameSharesValueWeighting ↓
Third Point 41,000,000$2,482,140,00022.00%
THUNDERBIRD PARTNERS LLP 1,711,643$103,623,00012.17%
SECTOR GAMMA AS 1,070,333$64,798,0009.42%
Veritas Asset Management LLP 10,179,102$616,243,0004.81%
13D Management LLC 194,807$11,794,0004.18%
Progressive Investment Management Corp 78,316$4,741,0003.69%
Aristotle Capital Management, LLC 6,846,307$414,476,0003.46%
ARGENT CAPITAL MANAGEMENT LLC 1,394,075$84,397,0003.37%
Lipe & Dalton 80,073$4,848,0003.14%
PURA VIDA INVESTMENTS, LLC 125,000$7,568,0003.00%
View complete list of BAXTER INTL INC shareholders